The Effects of Erector Spinae Plane Block on Bariatric Surgery.
Investigation of The Effects of The Erector Spinae Plane Block on The Quality Of Recovery After Laparoscopic Bariatric Surgery: A Prospective Randomized Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
The erector spinae plane block (ESPB) is a new technique that is increasingly used in the treatment of acute and chronic pain. Bariatric surgery is a surgical treatment method used in the treatment of morbid obesity and related comorbidities. Providing pain control in obese patients is a topic that remains up-to-date. Poorly controlled early postoperative pain impairs quality of recovery, increases the risk of postoperative pulmonary complications, and is a risk factor for the subsequent development of chronic pain. Therefore, optimizing acute postoperative analgesia is a priority in patients undergoing bariatric surgery. The primary aim of this prospective, randomized study is to evaluate the effect of ESPB on quality of recovery with the QoR-40 questionnaire in patients undergoing elective Laparoscopic Bariatric Surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2021
CompletedFirst Posted
Study publicly available on registry
August 25, 2021
CompletedStudy Start
First participant enrolled
September 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 27, 2022
CompletedOctober 28, 2022
October 1, 2022
1 year
August 21, 2021
October 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of Recovery (QoR-40) score
QoR-40, a 40-item questionnaire that provides a global score and subscores across five dimensions: patient support, comfort, emotions, physical independence, and pain. Each item is rated on a scale of 1-5, providing a minimum score of 40 and maximum of 200. The increase in scores show high quality of recovery.
postoperative 24th hour
Secondary Outcomes (7)
Postoperative pain: numeric rating scale (NRS)
Postoperative 48 hour
Analgesic consumption
Postoperative 48 hour
Side effects
24 hours
Sedation score
Postoperative 48 hour
mobilization time
Postoperative 24 hour
- +2 more secondary outcomes
Study Arms (2)
Group N
SHAM COMPARATORThe patients in Group N will not receive any intervention. Patients will receive standard multimodal analgesia comprising paracetamol, tenoxicam, and tramadol. The pain intensity will be evaluated with the 0-10 Numeric Rating Scale (NRS). NRS are the simple and most commonly used scales.11 The numerical scale is most commonly 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."
Group ESPB
EXPERIMENTALThe patients in the group ESPB will be placed in sitting pozition. A convex probe ultrasound transducer will be place in a longitudinal parasagittal orientation about 3 cm lateral to spinous process. Local anesthetic (20 ml 0.25% bupivacaine) will be injected bilaterally into the fascial plane on the deep aspect of erector spinae muscle. Standard perioperative and postoperative analgesia protocol will be given and postoperative pain levels will be determined by Numerical rating scale (NRS)
Interventions
Patients will receive standard multimodal analgesia comprising paracetamol, tenoxicam, and tramadol. The pain intensity during rest and motion will be evaluated with the 0-10 Numeric Rating Scale (NRS). NRS scores for pain and postoperative opioid consumption will be evaluated at 15th and 30th minutes, 1st, 2nd, 6th, 12th, 24th hours, 2nd day.
Patients in the ESPB group will be placed in a sitting position. A convex probe ultrasound transducer will be placed in a longitudinal parasagittal orientation approximately 3 cm lateral to the spinous process. Local anesthetic (20 ml 0.25% bupivacaine) will be injected bilaterally into the fascial plane on the deep face of the erector spinae muscle. Standard perioperative and postoperative analgesia protocol will be given and postoperative pain levels will be determined by Numerical Rating Scale (NRS). NRS scores for pain and postoperative opioid consumption will be evaluated at 15th and 30th minutes, 1st, 2nd, 6th, 12th, 24th hours, 2nd day.
Eligibility Criteria
You may qualify if:
- Scheduled for elective laparoscopic bariatric surgery
You may not qualify if:
- a history of allergy to local anesthetics
- known coagulation disorders
- infection near the puncture site
- Chronic opioid intake
- Patient with psychiatric disorders
- Can not communicate in Turkish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karaman Training and Research Hospital
Karaman, 70200, Turkey (Türkiye)
Related Publications (1)
Toprak H, Basaran B, Toprak SS, Et T, Kumru N, Korkusuz M, Bilge A, Yarimoglu R. Efficacy of the Erector Spinae Plane Block for Quality of Recovery in Bariatric Surgery: a Randomized Controlled Trial. Obes Surg. 2023 Sep;33(9):2640-2651. doi: 10.1007/s11695-023-06748-3. Epub 2023 Jul 24.
PMID: 37488349DERIVED
Study Officials
- STUDY DIRECTOR
Betul Basaran, MD, DESA
Karaman Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2021
First Posted
August 25, 2021
Study Start
September 10, 2021
Primary Completion
September 27, 2022
Study Completion
October 27, 2022
Last Updated
October 28, 2022
Record last verified: 2022-10